Stay updated with breaking news from Kidney Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WINSTON-SALEM, N.C., June 11, 2024 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an...
ProKidney Corp. (NASDAQ:PROK – Get Free Report) shares were up 4.7% during trading on Tuesday . The stock traded as high as $3.62 and last traded at $3.53. Approximately 29,186 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 688,385 shares. The stock had previously closed at $3.37. […]
ProKidney Corp. (NASDAQ:PROK – Get Free Report) SVP Darin J. Weber sold 16,438 shares of the stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $2.51, for a total value of $41,259.38. Following the completion of the transaction, the senior vice president now owns 155,194 shares of […]
ProKidney Corp. (NASDAQ:PROK – Get Free Report) SVP Darin J. Weber sold 16,438 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $2.51, for a total transaction of $41,259.38. Following the sale, the senior vice president now owns 155,194 shares of […]
ProKidney Corp. (NASDAQ:PROK – Get Free Report) SVP Darin J. Weber sold 17,238 shares of ProKidney stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of $2.50, for a total value of $43,095.00. Following the sale, the senior vice president now directly owns 172,432 shares of the company’s […]